Novo Nordisk A/S (NVO) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
NVO Stock Price Trajectory (2011–2026)
As of March 1, 2026, Novo Nordisk A/S (NVO) trades at $37.45, representing a -58.7% return over the past year. The stock has delivered a +0.6% return over five years, reflecting significant long-term value creation.
The stock reached its all-time high of $148.15 on June 25, 2024. From this peak, NVO has corrected -74.7%, currently trading 34% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers ABBV (+11.0% 1Y), AMGN (+26.0% 1Y), and GILD (+30.3% 1Y), NVO has underperformed the peer group average. Compare NVO vs ABBV →
Historical Price Data
Showing 30 of 3,650 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 37.54 | 37.86 | 37.33 | 37.45 | 37 | -0.45% |
| 2026-02-26 | 37.83 | 38.07 | 37.31 | 37.62 | 37 | -1.42% |
| 2026-02-25 | 37.70 | 38.24 | 37.65 | 38.16 | 38 | -1.11% |
| 2026-02-24 | 38.50 | 39.07 | 38.36 | 38.59 | 38 | -2.62% |
| 2026-02-23 | 40.19 | 41.09 | 39.34 | 39.63 | 39 | -16.43% |
| 2026-02-20 | 47.69 | 47.75 | 47.03 | 47.42 | 47 | -2.13% |
| 2026-02-19 | 48.72 | 48.77 | 48.19 | 48.45 | 8.24M | -1.58% |
| 2026-02-18 | 48.84 | 49.35 | 48.63 | 49.23 | 11.28M | +0.12% |
| 2026-02-17 | 49.11 | 49.29 | 48.91 | 49.17 | 1.39M | -0.81% |
| 2026-02-13 | 49.30 | 49.84 | 49.20 | 49.57 | 10.14M | +1.31% |
| 2026-02-12 | 48.85 | 50.07 | 48.12 | 48.93 | 11.60M | +0.39% |
| 2026-02-11 | 48.73 | 48.96 | 48.08 | 48.74 | 12.24M | -0.77% |
| 2026-02-10 | 50.02 | 50.46 | 48.98 | 49.12 | 15.76M | -0.51% |
| 2026-02-09 | 50.13 | 51.09 | 49.01 | 49.37 | 30.01M | +3.63% |
| 2026-02-06 | 46.37 | 47.74 | 45.84 | 47.64 | 36.60M | +9.92% |
| 2026-02-05 | 45.05 | 45.67 | 43.24 | 43.34 | 53.67M | -8.16% |
| 2026-02-04 | 47.95 | 49.10 | 46.47 | 47.19 | 46.64M | -6.18% |
| 2026-02-03 | 58.35 | 58.64 | 49.96 | 50.30 | 69.68M | -14.64% |
| 2026-02-02 | 57.91 | 59.30 | 57.79 | 58.93 | 16.62M | -0.84% |
| 2026-01-30 | 59.27 | 59.91 | 58.59 | 59.43 | 12.04M | +0.17% |
| 2026-01-29 | 59.93 | 59.93 | 58.80 | 59.33 | 15.78M | -1.66% |
| 2026-01-28 | 61.48 | 61.56 | 59.99 | 60.33 | 16.17M | -4.07% |
| 2026-01-27 | 62.89 | 63.49 | 62.49 | 62.89 | 13.38M | -1.70% |
| 2026-01-26 | 62.88 | 64.00 | 62.68 | 63.98 | 20.07M | +2.76% |
| 2026-01-24 | 63.40 | 64.16 | 62.02 | 62.26 | 26.82M | 0.00% |
| 2026-01-23 | 63.40 | 64.16 | 62.03 | 62.26 | 28.01M | +0.05% |
| 2026-01-22 | 61.44 | 62.44 | 61.04 | 62.23 | 20.25M | +4.91% |
| 2026-01-21 | 60.01 | 60.17 | 57.56 | 59.32 | 30.56M | -2.24% |
| 2026-01-20 | 60.22 | 62.18 | 59.96 | 60.68 | 30.36M | -2.65% |
| 2026-01-16 | 59.91 | 62.40 | 59.24 | 62.33 | 43.19M | +9.12% |
See NVO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVO Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare NVO vs AGIO
See how NVO stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has NVO stock performed recently?
NVO declined -58.7% over the past year, below its 5-year annualized CAGR of +0.6%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is NVO's all-time high price?
Novo Nordisk A/S reached $148.15 on 2024-06-25. The 52-week high is $91.90. Current 1-year return of -58.7% places the stock further from historical peaks.
Where can I download NVO historical price data?
This page provides NVO daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.